Acalabrutinib
About
Therapy type: Targeted therapy
Therapy strategy: BTK inhibition
Mappings
NCI Thesaurus: Acalabrutinib (coding:ncit:C113442)
RxNorm: acalabrutinib (coding:rxcui:1986808, coding:omop:792764)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| HSE (1) | TP53 Somatic variants | Chronic Lymphocytic Leukemia | Acalabrutinib | |
| HSE (1) | TP53 deletion | Chronic Lymphocytic Leukemia | Acalabrutinib | |
| HSE (1) | 17p deletion | Chronic Lymphocytic Leukemia | Acalabrutinib |